Clinical Trials in North Carolina

Showing 8841-8860 of 15,496 trials

A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)

NCT02553330

A phase 2 study to find out if the drug ruxolitinib Phosphate Cream is safe and has beneficial effects in people who have alopecia areata (partial or complete hair loss) when applied to the skin.

Alopecia Areata

Incyte Corporation90 participantsStarted Nov 2015

Birmingham, Alabama, United States • Hot Springs, Arkansas, United States • New Haven, Connecticut, United States +15 more locations

COMPLETED46 miles

Evaluation of Biomarkers of Traumatic Brain Injury

NCT01426919

The primary objective of this study is to evaluate the utility of the Banyan UCH-L1/GFAP Detection Assay as an aid in the evaluation of suspected traumatic brain injury (Glasgow Coma Scale score 9-15) in conjunction with other clinical information within 12 hours of injury to assist in determining the need for a CT scan of the head.

Traumatic Brain Injury

Banyan Biomarkers, Inc2,011 participantsStarted Dec 2012

San Diego, California, United States • Hartford, Connecticut, United States • Gainesville, Florida, United States +21 more locations

A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)

Evaluation of Biomarkers of Traumatic Brain Injury

Find Trials by Condition in North Carolina

PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation

Fatty Acids and Executive Function Development in 7-12 Year Olds

Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation and Pain

INC280 in Healthy Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic Function

Single and Multiple Dose Escalation Study to Assess the Safety and Tolerability of CJM112 in Psoriasis

The CDR Implementation Trial

Robotic Bronchoscopy for Peripheral Pulmonary Lesions

An Efficacy and Safety Study of BG00011 in Participants With Idiopathic Pulmonary Fibrosis

Investigate Effect of Secukinumab on the PK of Midazolam in Patients With Mod to Sev Plaque Psoriasis

Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis

Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose CFZ533 in Rheumatoid Arthritis Patients

Phase 1b Trial of BGJ398/BYL719 in Solid Tumors

Registry Evaluation of a Double Balloon Accessory Device

Safety, Tolerability, and Efficacy Study of CLL442 in Patients With Cutaneous Squamous Cell Carcinoma in Situ (SCCis)

A Phase I Study for Safety and Tolerability of AL002.

A Study of MEK162 and AMG 479 in Patients With Selected Solid Tumors

Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular Edema